bpc 157 everlife BPC-157 Dosage Protocol: Injection Guide BPC-157 Reference Material | COA,
Description
Safety: Preclinical studies showed no acute toxicity across organ systems and no evidence of mutagenicity or teratogenicity
The use of folic acid for the treatment of pernicious anemia patients began with the availability of synthetic folic acid in 1945 (79)
The injection should be administered only under medical supervision
P.HeathfieldT
Until that day comes, we will be here to help
It is dosed between 300 mcg and 1,000 mcg (1 mg) daily, either subcutaneously or via an intranasal applicator
